残余脂蛋白胆固醇与冠心病相关性的研究进展-国际内科前沿杂志-科技核心数据库

相关机构

残余脂蛋白胆固醇与冠心病相关性的研究进展

Research progress of correlation between residual lipoprotein cholesterol and coronary heart disease

被引量： ES评分0 浏览量：87

全文阅读下载引用收藏

DOI	10.12208/j.ijim.20240001
刊名	国际内科前沿杂志 International Journal of Internal Medicine
年，卷(期)	2024, 5(1)
作者	金波*,
作者单位	哈尔滨职业技术学院黑龙江哈尔滨 ;
摘要	冠状动脉粥样硬化性心脏病(Coronary Heart Disease，CHD)对人类生命健康存在严重威胁。在我国最常见的心血管疾病就是冠心病^[1,2]，CHD的潜伏期比较长，但是发病率、死亡率均较高，防控形式严峻。随着对CHD的规范化健康管理，以及他汀类药物的广泛使用，LDL-C达标率日益增加。然而，部分患者即使LDL-C水平达标，仍有心血管事件发生。深入研究CHD风险因素发现，残余脂蛋白胆固醇（RLP-C）对CHD有着非常重要的预测价值。有研究表明，RLP-C是冠心病的危险因子^[3,4]，为探讨RLP-C与CHD的相关性，本文综述如下。 Coronary Heart Disease (CHD) poses a serious threat to human life and health. The most common cardiovascular disease in China is coronary heart disease^[1,2]. The incubation period of CHD is relatively long, but the morbidity and mortality are high, and the prevention and control forms are severe. With the standardized health management of CHD and the widespread use of statins, LDL-C compliance is increasing. However, some patients still have cardiovascular events even if LDL-C levels are up to standard. In-depth study of CHD risk factors found that residual lipoprotein cholesterol (RLP-C) has a very important predictive value for CHD. Studies have shown that RLP-C is a risk factor for coronary heart disease^[3,4]. In order to explore the correlation between RLP-C and CHD, this paper summarizes as follows.
关键词	残余脂蛋白胆固醇；冠心病；危险因子 Residual lipoprotein cholesterol; Coronary heart disease; Risk factor
基金项目
页码	1-4

参考文献
相关文献

[1] Association B. H., Prevention B. D., Association T., et al. 基层心血管病综合管理实践指南2020 %J 中国医学前沿杂志(电子版).2020;12(08): 1-73.
[2] 《中国心血管健康与疾病报告》2021（冠心病部分内容）%J 心肺血管病杂志.2023;42(11): 1093-6.
[3] Xuemei Z., Yifei W., Wei L., et al. Cumulative Remnant Cholesterol as a causal risk factor for Ischemic Heart Disease: A Prospective Cohort Study. %J Current problems in cardiology.2023;49(2): 102215-.
[4] Lim G. B. Inclusion of remnant cholesterol improves risk prediction for ischaemic heart disease. Nature reviews Cardiology.2022;19(8): 504.
[5] Zhao Y., Zhuang Z., Li Y., et al. Elevated blood remnant cholesterol and triglycerides are causally related to the risks of cardiometabolic multimorbidity. Nat Commun. 2024;15(1): 2451.
[6] Chait A. Multifactorial chylomicronemia syndrome. Current Opinion in Endocrinology, Diabetes & Obesity. 2024; 31(2): 78-83.
[7] 卜晓丹, 卜晓翠. 不同分型冠心病患者血清指标的变化水平研究.菏泽医学专科学校学报.2023;35(03): 5-8+32.
[8] Zhang Y., Gao Y., Zhou G., et al. Centerline-supervision multi-task learning network for coronary angiography segmentation.Biomed Signal Process Control.2023;82 (104510.
[9] Feng R., Lin Q., Wei D., et al. Tongxinluo capsule in combination with conventional therapies for stable angina pectoris: A meta-analysis and systematic review.Medicine. 2023;102(41):&
[10] Shao H., Huang Y., Xu D., et al. A Systematic Review and Meta-Analysis on the Efficacy of Puerarin Injection as Adjunctive Therapy for Unstable Angina Pectoris. Frontiers in cardiovascular medicine.2022;9 (2297-055X (Print)):&
[11] 白潇萱, 贾海波. 坏死性凋亡在动脉粥样硬化及相关疾病中的作用.心血管康复医学杂志.2023;32(02): 134-8.
[12] Kopin L., Lowenstein C. J. Dyslipidemia. Annals of Internal Medicine.2017;167(11):&
[13] 任妹, 夏洪娇, 刘剑荣, et al. 冠心病发生及脂代谢紊乱与血浆致动脉硬化指数的相关性研究.当代医学.2021; 27(13): 8-10.
[14] Erica F., Sarah J., Renee S., et al. Biological Variability of Small Dense LDL, HDL3, and Triglyceride-Rich Lipoprotein Cholesterol %J American Journal of Clinical Pathology. 2021;156(Supplement1): S4-S.
[15] 冯丹, 李娜, 侯东燕. 血清残粒脂蛋白胆固醇浓度与急性心肌梗死相关性分析.首都医科大学学报.2023;44(05): 872-6.
[16] Kunimura A., Miura K. Is remnant cholesterol a new therapeutic target for preventing hypertension? Hypertension Research. 2024;47(5): 1227-8.
[17] Wang K., Wang R., Yang J., et al. Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment. Frontiers in cardiovascular medicine.2022;9(913869.
[18] Filtz A., Parihar S., Greenberg G. S., et al. New approaches to triglyceride reduction: Is there any hope left?American Journal of Preventive Cardiology.2024; 18(2666-6677 (Electronic)):&
[19] Nordestgaard B. G., Freiberg J. J., Varbo A. Extreme nonfasting remnant cholesterol versus extreme low-density lipoprotein cholesterol as contributors of cardiovascular disease and all-cause mortality in 90,000 individuals from the general population. Atherosclerosis. 2015;241(1):&
[20] 巨名飞, 刘超, 于健, et al. 急性心肌梗死患者残余胆固醇及血常规参数变化的意义.国际老年医学杂志.2020; 41(06): 364-6.
[21] Guo D. C., Gao J. W., Wang X., et al. Remnant cholesterol and risk of incident hypertension: a population-based prospective cohort study. LID - 10.1038/s41440-023-01558-7&
[22] 孙楷文, 王虹艳. 残粒胆固醇在动脉粥样硬化相关疾病中的研究进展.中华高血压杂志.2023;31(05): 419-24.
[23] Xiong C.-C., Gao F., Zhang J.-H., et al. Investigating the impact of remnant cholesterol on new-onset stroke across diverse inflammation levels: Insights from the China Health and Retirement Longitudinal Study (CHARLS). International Journal of Cardiology. 2024;405(1874-1754 (Electronic)):&
[24] Qian S., You S., Sun Y., et al. Remnant Cholesterol and Common Carotid Artery Intima-Media Thickness in Patients With Ischemic Stroke. Circulation Cardiovascular imaging.2021;14(4): e010953.
[25] Cheng Q., Li Z., Wang X., et al. Relation Between New York Heart Association Functional Class and Remnant Cholesterol, and Non-high Density Lipoprotein Cholesterol in Coronary Heart Disease Patients With Type 2 Diabetes Mellitus.Angiology.2022;74(1): 39-46.
[26] Wu X., Qiu W., He H., et al. Associations of the triglyceride-glucose index and remnant cholesterol with coronary artery disease: a retrospective study. %J Lipids in health and disease.2024;23(1): 45-.
[27] J. H., P. B., B. A., et al. Interstitial postprandial hyperlipidemia and remnant lipoproteins in type 2 diabetes mellitus %J Atherosclerosis.2021;331(e7-e.
[28] Vergès B. Dyslipidemia in Type 1 Diabetes: AMaskedDanger %J Trends in Endocrinology & Metabolism.2020;31(6): 422-34.
[29] 王钰哲, 孔璐璐, 葛丹, et al. 残余胆固醇与糖尿病视网膜病变相关性的研究.中国糖尿病杂志.2023;31(10): 741-4.

相关学者

相关机构